Novo Rebrands and Refines Global Strategy as Race for Obesity Market Dominance Escalates
Novo Nordisk unveils a major corporate rebranding to Novo as CEO Mike Doustdar outlines a revised obesity strategy to address rising competition from Eli Lilly.
Minute To Know | News